FAK inhibition, together with a decrease in Akt activity upon treatment with the examined extracts, suggested that the extracted compound could profoundly reduce cell growth and migration, and thus, the invasiveness of U87MG glioblastoma cells. The gene discussed is PTK2; the disease is glioblastoma.